Asset Details
Do you wish to reserve the book?
Control of Coagulation Abnormalities with Sodium Benzoate in Patients with Argininemia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Control of Coagulation Abnormalities with Sodium Benzoate in Patients with Argininemia
Do you wish to request the book?
Control of Coagulation Abnormalities with Sodium Benzoate in Patients with Argininemia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Control of Coagulation Abnormalities with Sodium Benzoate in Patients with Argininemia
2025
Overview
AimThis study aimed to evaluate coagulation disorders in patients with argininemia associated with arginase 1 gene mutations and the control of these disorders with sodium benzoate treatment.Materials and MethodsFive argininemia patients followed up in the Pediatric Metabolism Clinic in University of Health Sciences Türkiye, Başakşehir Çam and Sakura City Hospital, were included in this study. The patients initially received protein-restricted diet treatment, while their ammonia, platelet count, liver enzymes and coagulation parameters were measured regularly. Later, sodium benzoate was added to the treatment and the same parameters were measured at 1-month intervals.ResultsIn the coagulation parameters measured after sodium benzoate treatment, one out of the five patients showed complete improvement, three had partial improvement, and one had no change. In the patients with coagulation disorders, factor VII and IX levels were low, while arginine levels remained above 250 µmol/L.ConclusionThe pathophysiology of coagulation disorders in patients with argininemia has not yet been fully elucidated, but it is thought that high arginine levels may affect the synthesis of short-lived coagulation factors. Adding sodium benzoate to dietary therapy may contribute to both the control of arginine levels and an improvement in coagulation parameters. This study demonstrates the importance of coagulation monitoring in those patients with argininemia and the potential therapeutic role of sodium benzoate.
